Guojin Securities said that GLP-1 drugs will continue to exp...

Moomoo AI Oct 28, 2023 18:59

Guojin Securities said that GLP-1 drugs will continue to expand market space due to demand for treatment of chronic diseases. Special attention is paid to the investment opportunities of Huadong Pharmaceutical and Pharmaceuticals.

Guojin Securities: GLP-1's epoch-making variety is booming, and attention to the weight reduction industry chain continues to rise

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

See Original

Report

7120 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

3505Followers

0Following

8331Visitors